Telerehabilitation Early After Stroke
ConditionCerebral Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTRCare, Inc.
About this trial
The goal of this clinical trial is to assess the safety and feasibility of providing extra doses of rehabilitation therapy for persons with a recent stroke. The therapy treatment targets to improve arm function by introducing telerehabilitation to the bedside of participants during the inpatient rehab admission period. Participants will use a newly developed functional training system (HandyMotion) to access therapy treatment program directly from their hospital room. HandyMotion is a sensor-based training system that can connect to the TV set in the hospital room, enabling patients to access their therapy training program to practice rehab-oriented games and exercises ad libitum, at any time of the day.
Eligibility criteria
Qualifiers
Age 18 years or older
Stroke that is radiologically verified, due to ischemia or to intracerebral hemorrhage, and with time of stroke onset <30 days prior to enrollment; or traumatic brain injury.
Unilateral arm motor deficits that are neither trivial (no arm weakness) or devastating (arm plegia). This requires that the baseline Box & Block Test score with affected arm to be at least 1 block in 60 seconds but no more than 90% of the number of blocks with the good arm.
Possess enough arm movement to participate in therapy
Disqualifiers
A major, active, coexistent neurological or psychiatric disease that would limit study participation, e.g., advanced dementia
Expectation that patient's cognitive status will likely interfere substantially with playing assigned games or exercises
Deficits in communication that interfere with reasonable study participation
Lacking visual acuity, with or without corrective lens, of 20/50 or better in at least one eye
Trial design
Treatments tested in this trial
- HandyMotion Treatment Program
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
TRCare, Inc.
Lead sponsor
Providence St. Jude Medical Center
Collaborator
Source ClinicalTrials.gov